Menu Close

VSV-EBOPLUS brings together 11 leading international, both clinical and high-tech, vaccine research institutes and non-profit organization from 5 EU countries, Brazil and clinical sites in USA and Africa. The partners provide state-of-the art facilities and clinical vaccination research infrastructures that will work together to facilitate Ebola vaccine development.

The VSV-EBOPLUS project is coordinated by the Sclavo Vaccines Association (, a non-profit organization devoted to support research and development of human vaccines.

Sclavo Vaccines Association (SVA) Italy  
University of Geneva (UNIGE) Switzerland
Merck Sharp & Dohme Corp. (MSD) USA
University of Gothenburg (UGOT) Sweden
University of Siena (UNISI) Italy
Academisch Ziekenhuis Leiden (LUMC) The Netherlands
Eberhard Karls Universitaet Tuebingen (EKUT) Germany
Universidade De Sao Paulo (USP) Brazil
Spiez Laboratory, Federal Office for Civil Protection (VBS-LS) Switzerland
Centre de Recherches Médicales de Lambaréné  (CERMEL) Gabon